Visual-digital knowledge execution for scalable, compliant advanced therapy development and manufacturing
Minerva transforms fragmented process, manufacturing, quality, and operational information into visual-digital knowledge systems that help advanced therapy teams execute faster, reduce risks, and scale with greater consistency.
Our multidisciplinary SMEs integrate manufacturing, quality systems, investigations, visualization, digitalization, and risk management to support compliant product development and commercialization across the full ATMP lifecycle.
Minerva’s experts bring hands-on experience across advanced therapy manufacturing operations, including apheresis collection, activation, transduction, expansion, formulation, cryopreservation, potency testing, purity analysis, and viability assessments.
Minerva creates highly visual process models and operational maps that help multidisciplinary teams rapidly understand complex workflows, technical interactions, dependencies, and risks.
Our visual language improves communication, accelerates technical decisions, strengthens technology transfer, simplifies onboarding and training, and supports scalable manufacturing and quality operations.
We structure quality-relevant operational data into digital systems that help teams identify recurring risks, process gaps, hidden trends, operational bottlenecks, and opportunities for continuous improvement.
Minerva converts process experience, manufacturing data, investigations, and operational knowledge into structured digital assets that strengthen pharmaceutical quality systems and support sustainable GMP compliance aligned with ICH Q9 principles.
Our highly visual process characterization and digital risk frameworks help teams identify, evaluate, and mitigate risks across all development and manufacturing stages.
Minerva integrates process maps, risk files, investigations, and operational controls into traceable visual-digital systems that accelerate compliant execution and reduce issue recurrence.
Minerva combines technical investigations, quality investigations, visualization, and risk management into integrated response systems that accelerate issue resolution while strengthening the long-term reliability of your operations. Our R3 and C3 investigation methodologies transform deviations and technical events into operational knowledge that continuously improves the product quality system.
Learn more about Minerva’s C3 technical investigations and R3 quality investigations here.
Minerva supports technical and quality investigations throughout process development, GMP readiness, technology transfer, clinical manufacturing, commercialization, and continuous improvement.
This phase-appropriate approach ensures investigations strengthen operational knowledge rather than simply closing records.
Our multidisciplinary investigation teams address issues across manufacturing, quality control, quality systems, supply chain, materials management, laboratories, and automation systems.
This integrated approach reduces siloed investigations and enables stronger CAPAs, improved risk controls, and greater long-term operational reliability.
Minerva helps advanced therapy organizations transition from manually dependent operations into scalable, automation-ready manufacturing and quality systems.
By structuring process knowledge into visual-digital operational intelligence, we create the foundation required for successful automation, robotics integration, AI-enabled systems, and future manufacturing scalability.
Our experts combine advanced therapy manufacturing knowledge with automation modeling and robotics implementation experience to help organizations design scalable and compliant automated operations.
This bridges scientific process understanding with practical execution infrastructure designed for long-term operational growth.
Minerva captures, organizes, visualizes, and digitalizes scientific, manufacturing, and quality information into AI-ready knowledge systems that improve automation accuracy, reliability, and scalability.
This is how automation becomes compliant, traceable, and operationally sustainable.
Transforming advanced therapy operations through visual-digital knowledge, compliant execution, and risk-intelligent innovation.
